Morgagni-Stewart-Morel Syndrome, also known as
hyperostosis frontalis interna, is a rare neurological disorder
characterized by abnormal thickening of the frontal bone of the skull.
It primarily affects women, especially postmenopausal women, although
men and premenopausal women can also be affected. This condition is
generally non-life-threatening and underdiagnosed due to its asymptomatic
nature in most cases.

– Frontal headaches
– Memory impairment
– Personality changes
– Depression
– Visual disturbances
– Sleep disturbances

The exact cause of Morgagni-Stewart-Morel Syndrome remains unknown.
However, several factors such as hormonal imbalances, genetic predisposition,
and metabolic abnormalities may contribute to its development.

Diagnosis of Morgagni-Stewart-Morel Syndrome involves a combination of
medical history evaluation, physical examination, neuroimaging techniques
like X-rays and CT scans, and ruling out other potential causes of similar
symptoms.

There is no specific cure for Morgagni-Stewart-Morel Syndrome. Treatment is
usually focused on managing the symptoms and improving the patient’s quality
of life. This may involve medication to address pain, mood disorders, and
sleep disturbances. Supportive therapies like counseling, occupational therapy,
and cognitive rehabilitation can also be beneficial.

The prognosis of Morgagni-Stewart-Morel Syndrome is generally favorable,
as it does not lead to a significant decrease in life expectancy. With proper
symptom management and support, individuals can lead fulfilling lives despite
the challenges posed by the syndrome.